Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform
Go back to Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform| (NASDAQ: CODX) | Delayed: 1.50 -0.06 (3.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.56 | 52 Week High | $ | |||
| Open | $1.60 | 52 Week Low | $ | |||
| Day High | $1.64 | P/E | N/A | |||
| Day Low | $1.41 | EPS | $ | |||
| Volume | 317,574 | |||||
